跳至主要内容
临床试验/NCT03682042
NCT03682042进行中(未招募)不适用

A Cluster Randomized Clinical Trial of Umbilical Cord Milking Versus Early Cord Clamping on Short and Long-term Outcomes in Neonates Who Are Non-Vigorous at Birth

Nemours Children's Clinic16 个研究点 分布在 1 个国家目标入组 3,442 人开始时间: 2022年10月17日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
3,442
试验地点
16
主要终点
Neurodevelopmental Outcome at 2 Years of Age

研究概览

简要总结

An extension of the CORDMILK trial, the CORDMILK follow-up trial will evaluate the neurodevelopmental outcomes at 22-26 months age of term/late preterm infants who were non-vigorous at birth and received umbilical cord milking (UCM) or early cord clamping (ECC).

详细描述

The CORDMILK Follow-up trial will examine the difference in survival and neurodevelopmental impairment of infants who were non-vigorous at birth and enrolled in the CORDMILK trial. The difference in survival and neurodevelopmental impairment in infants who received UCM and ECC will be assessed using standardized neurological and developmental assessment tools at 22-26 months of age.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Prevention
盲法
Single (Outcomes Assessor)

盲法说明

Neurodevelopmental providers will be blinded to the randomization of the toddler during the examination.

入排标准

年龄范围
22 Months 至 26 Months(Child)
性别
All
接受健康志愿者

入选标准

  • Enrolled in CORDMILK trial
  • Non-vigorous at birth

排除标准

  • 未提供

研究组 & 干预措施

Umbilical Cord Milking

Active Comparator

At delivery, the umbilical cord is grasped, and blood is pushed toward the infant 4 times before the cord is clamped. This procedure infuses a placental transfusion of blood into the infant and can be done in 10-15 seconds.

干预措施: Umbilical Cord Milking (Other)

Early Cord Clamping

No Intervention

The umbilical cord is clamped immediately after the delivery (within 60 seconds).

结局指标

主要结局

Neurodevelopmental Outcome at 2 Years of Age

时间窗: 22-26 months

Neurodevelopmental assessment will be performed by the trained and experienced examiner who will be blinded to the interventions. Severe neurodevelopmental impairment will be defined having at least one of the following: BSID (IV) composite cognitive score \<70, GMFCS level 3-5, blindness (vision \<20/200), or hearing impairment requiring hearing aids/cochlear implant. Moderate neurodevelopmental impairment will be defined as having a cognitive composite score 70-84, GMFCS level 2, unilateral blindness (vision/20/200 in only one eye), or hearing impairment with no amplification/cochlear implant.

次要结局

  • Neurodevelopmental Outcome at 1 Year of Age(10-14 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Zubair Aghai

Professor of Pediatrics

Nemours Children's Clinic

研究点 (16)

Loading locations...

相似试验